nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—Necrosis—Niacin—atherosclerosis	0.00991	0.0143	CcSEcCtD
Dicyclomine—Tingling sensation—Niacin—atherosclerosis	0.00968	0.014	CcSEcCtD
Dicyclomine—Numbness—Pravastatin—atherosclerosis	0.00924	0.0133	CcSEcCtD
Dicyclomine—Sensory loss—Pravastatin—atherosclerosis	0.00884	0.0128	CcSEcCtD
Dicyclomine—Amnesia—Rosuvastatin—atherosclerosis	0.00826	0.0119	CcSEcCtD
Dicyclomine—Breast disorder—Rosuvastatin—atherosclerosis	0.00701	0.0101	CcSEcCtD
Dicyclomine—Amnesia—Lovastatin—atherosclerosis	0.007	0.0101	CcSEcCtD
Dicyclomine—Amnesia—Ezetimibe—atherosclerosis	0.00686	0.0099	CcSEcCtD
Dicyclomine—Muscular weakness—Rosuvastatin—atherosclerosis	0.00684	0.00987	CcSEcCtD
Dicyclomine—Amnesia—Simvastatin—atherosclerosis	0.00654	0.00944	CcSEcCtD
Dicyclomine—Amnesia—Pravastatin—atherosclerosis	0.00592	0.00854	CcSEcCtD
Dicyclomine—Breast disorder—Ezetimibe—atherosclerosis	0.00583	0.00841	CcSEcCtD
Dicyclomine—Muscular weakness—Ezetimibe—atherosclerosis	0.00569	0.00821	CcSEcCtD
Dicyclomine—Diplopia—Pravastatin—atherosclerosis	0.00556	0.00802	CcSEcCtD
Dicyclomine—Affect lability—Pravastatin—atherosclerosis	0.00547	0.0079	CcSEcCtD
Dicyclomine—Face oedema—Niacin—atherosclerosis	0.00545	0.00786	CcSEcCtD
Dicyclomine—Muscular weakness—Simvastatin—atherosclerosis	0.00542	0.00783	CcSEcCtD
Dicyclomine—Urinary retention—Niacin—atherosclerosis	0.00537	0.00775	CcSEcCtD
Dicyclomine—Mood swings—Pravastatin—atherosclerosis	0.00527	0.0076	CcSEcCtD
Dicyclomine—Erectile dysfunction—Lovastatin—atherosclerosis	0.00523	0.00755	CcSEcCtD
Dicyclomine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00513	0.00741	CcSEcCtD
Dicyclomine—Muscular weakness—Niacin—atherosclerosis	0.00498	0.00719	CcSEcCtD
Dicyclomine—Abdominal distension—Niacin—atherosclerosis	0.00491	0.00709	CcSEcCtD
Dicyclomine—Muscular weakness—Pravastatin—atherosclerosis	0.0049	0.00707	CcSEcCtD
Dicyclomine—Erectile dysfunction—Simvastatin—atherosclerosis	0.00489	0.00706	CcSEcCtD
Dicyclomine—Abdominal distension—Pravastatin—atherosclerosis	0.00484	0.00698	CcSEcCtD
Dicyclomine—Mental disorder—Rosuvastatin—atherosclerosis	0.0047	0.00678	CcSEcCtD
Dicyclomine—Erectile dysfunction—Niacin—atherosclerosis	0.00449	0.00648	CcSEcCtD
Dicyclomine—Erectile dysfunction—Pravastatin—atherosclerosis	0.00443	0.00639	CcSEcCtD
Dicyclomine—Angioedema—Rosuvastatin—atherosclerosis	0.00427	0.00616	CcSEcCtD
Dicyclomine—Immune system disorder—Ezetimibe—atherosclerosis	0.00403	0.00581	CcSEcCtD
Dicyclomine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00402	0.0058	CcSEcCtD
Dicyclomine—Mental disorder—Ezetimibe—atherosclerosis	0.00391	0.00564	CcSEcCtD
Dicyclomine—Hypoaesthesia—Niacin—atherosclerosis	0.00389	0.00561	CcSEcCtD
Dicyclomine—Erythema—Ezetimibe—atherosclerosis	0.00388	0.0056	CcSEcCtD
Dicyclomine—Confusional state—Rosuvastatin—atherosclerosis	0.00384	0.00555	CcSEcCtD
Dicyclomine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00383	0.00552	CcSEcCtD
Dicyclomine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00374	0.00539	CcSEcCtD
Dicyclomine—Vision blurred—Lovastatin—atherosclerosis	0.00373	0.00538	CcSEcCtD
Dicyclomine—Mental disorder—Simvastatin—atherosclerosis	0.00373	0.00538	CcSEcCtD
Dicyclomine—Erythema—Simvastatin—atherosclerosis	0.0037	0.00534	CcSEcCtD
Dicyclomine—Ill-defined disorder—Lovastatin—atherosclerosis	0.00367	0.0053	CcSEcCtD
Dicyclomine—Eye disorder—Niacin—atherosclerosis	0.00365	0.00527	CcSEcCtD
Dicyclomine—Angioedema—Lovastatin—atherosclerosis	0.00362	0.00522	CcSEcCtD
Dicyclomine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.0036	0.0052	CcSEcCtD
Dicyclomine—Malaise—Lovastatin—atherosclerosis	0.00357	0.00515	CcSEcCtD
Dicyclomine—Cardiac disorder—Pravastatin—atherosclerosis	0.00357	0.00515	CcSEcCtD
Dicyclomine—Angioedema—Ezetimibe—atherosclerosis	0.00355	0.00512	CcSEcCtD
Dicyclomine—Malaise—Ezetimibe—atherosclerosis	0.0035	0.00505	CcSEcCtD
Dicyclomine—Vision blurred—Simvastatin—atherosclerosis	0.00349	0.00504	CcSEcCtD
Dicyclomine—Insomnia—Rosuvastatin—atherosclerosis	0.00345	0.00498	CcSEcCtD
Dicyclomine—Ill-defined disorder—Simvastatin—atherosclerosis	0.00344	0.00496	CcSEcCtD
Dicyclomine—Palpitations—Ezetimibe—atherosclerosis	0.00343	0.00495	CcSEcCtD
Dicyclomine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00342	0.00494	CcSEcCtD
Dicyclomine—Erythema—Niacin—atherosclerosis	0.0034	0.00491	CcSEcCtD
Dicyclomine—Angioedema—Simvastatin—atherosclerosis	0.00338	0.00488	CcSEcCtD
Dicyclomine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00336	0.00484	CcSEcCtD
Dicyclomine—Hypertension—Ezetimibe—atherosclerosis	0.00335	0.00484	CcSEcCtD
Dicyclomine—Malaise—Simvastatin—atherosclerosis	0.00334	0.00482	CcSEcCtD
Dicyclomine—Tension—Niacin—atherosclerosis	0.00334	0.00481	CcSEcCtD
Dicyclomine—Discomfort—Lovastatin—atherosclerosis	0.00333	0.0048	CcSEcCtD
Dicyclomine—Nervousness—Niacin—atherosclerosis	0.0033	0.00477	CcSEcCtD
Dicyclomine—Dry mouth—Lovastatin—atherosclerosis	0.0033	0.00476	CcSEcCtD
Dicyclomine—Tension—Pravastatin—atherosclerosis	0.00329	0.00474	CcSEcCtD
Dicyclomine—Discomfort—Ezetimibe—atherosclerosis	0.00327	0.00471	CcSEcCtD
Dicyclomine—Pain—Rosuvastatin—atherosclerosis	0.00326	0.0047	CcSEcCtD
Dicyclomine—Constipation—Rosuvastatin—atherosclerosis	0.00326	0.0047	CcSEcCtD
Dicyclomine—Confusional state—Lovastatin—atherosclerosis	0.00326	0.0047	CcSEcCtD
Dicyclomine—Nervousness—Pravastatin—atherosclerosis	0.00325	0.00469	CcSEcCtD
Dicyclomine—Dry mouth—Ezetimibe—atherosclerosis	0.00323	0.00466	CcSEcCtD
Dicyclomine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00323	0.00466	CcSEcCtD
Dicyclomine—Vision blurred—Niacin—atherosclerosis	0.0032	0.00462	CcSEcCtD
Dicyclomine—Confusional state—Ezetimibe—atherosclerosis	0.0032	0.00461	CcSEcCtD
Dicyclomine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00317	0.00457	CcSEcCtD
Dicyclomine—Vision blurred—Pravastatin—atherosclerosis	0.00316	0.00455	CcSEcCtD
Dicyclomine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00314	0.00453	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00312	0.0045	CcSEcCtD
Dicyclomine—Discomfort—Simvastatin—atherosclerosis	0.00311	0.00449	CcSEcCtD
Dicyclomine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00311	0.00448	CcSEcCtD
Dicyclomine—Angioedema—Niacin—atherosclerosis	0.00311	0.00448	CcSEcCtD
Dicyclomine—Ill-defined disorder—Pravastatin—atherosclerosis	0.00311	0.00448	CcSEcCtD
Dicyclomine—Anorexia—Lovastatin—atherosclerosis	0.00308	0.00444	CcSEcCtD
Dicyclomine—Angioedema—Pravastatin—atherosclerosis	0.00306	0.00441	CcSEcCtD
Dicyclomine—Syncope—Niacin—atherosclerosis	0.00305	0.0044	CcSEcCtD
Dicyclomine—Confusional state—Simvastatin—atherosclerosis	0.00305	0.0044	CcSEcCtD
Dicyclomine—Urticaria—Rosuvastatin—atherosclerosis	0.00303	0.00437	CcSEcCtD
Dicyclomine—Oedema—Simvastatin—atherosclerosis	0.00302	0.00436	CcSEcCtD
Dicyclomine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00302	0.00436	CcSEcCtD
Dicyclomine—Malaise—Pravastatin—atherosclerosis	0.00302	0.00436	CcSEcCtD
Dicyclomine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00301	0.00435	CcSEcCtD
Dicyclomine—Palpitations—Niacin—atherosclerosis	0.003	0.00434	CcSEcCtD
Dicyclomine—Loss of consciousness—Niacin—atherosclerosis	0.00299	0.00431	CcSEcCtD
Dicyclomine—Insomnia—Lovastatin—atherosclerosis	0.00292	0.00422	CcSEcCtD
Dicyclomine—Paraesthesia—Lovastatin—atherosclerosis	0.0029	0.00419	CcSEcCtD
Dicyclomine—Hypertension—Pravastatin—atherosclerosis	0.00289	0.00417	CcSEcCtD
Dicyclomine—Anorexia—Simvastatin—atherosclerosis	0.00288	0.00416	CcSEcCtD
Dicyclomine—Dyspnoea—Lovastatin—atherosclerosis	0.00288	0.00416	CcSEcCtD
Dicyclomine—Insomnia—Ezetimibe—atherosclerosis	0.00287	0.00414	CcSEcCtD
Dicyclomine—Paraesthesia—Ezetimibe—atherosclerosis	0.00285	0.00411	CcSEcCtD
Dicyclomine—Dyspepsia—Lovastatin—atherosclerosis	0.00284	0.0041	CcSEcCtD
Dicyclomine—Dry mouth—Niacin—atherosclerosis	0.00283	0.00408	CcSEcCtD
Dicyclomine—Dyspnoea—Ezetimibe—atherosclerosis	0.00283	0.00408	CcSEcCtD
Dicyclomine—Discomfort—Pravastatin—atherosclerosis	0.00282	0.00406	CcSEcCtD
Dicyclomine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00281	0.00405	CcSEcCtD
Dicyclomine—Decreased appetite—Lovastatin—atherosclerosis	0.00281	0.00405	CcSEcCtD
Dicyclomine—Dyspepsia—Ezetimibe—atherosclerosis	0.00279	0.00403	CcSEcCtD
Dicyclomine—Fatigue—Lovastatin—atherosclerosis	0.00279	0.00402	CcSEcCtD
Dicyclomine—Anaphylactic shock—Niacin—atherosclerosis	0.00277	0.004	CcSEcCtD
Dicyclomine—Oedema—Niacin—atherosclerosis	0.00277	0.004	CcSEcCtD
Dicyclomine—Pain—Lovastatin—atherosclerosis	0.00276	0.00399	CcSEcCtD
Dicyclomine—Constipation—Lovastatin—atherosclerosis	0.00276	0.00399	CcSEcCtD
Dicyclomine—Confusional state—Pravastatin—atherosclerosis	0.00275	0.00398	CcSEcCtD
Dicyclomine—Decreased appetite—Ezetimibe—atherosclerosis	0.00275	0.00397	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00274	0.00395	CcSEcCtD
Dicyclomine—Asthenia—Rosuvastatin—atherosclerosis	0.00274	0.00395	CcSEcCtD
Dicyclomine—Insomnia—Simvastatin—atherosclerosis	0.00273	0.00394	CcSEcCtD
Dicyclomine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00273	0.00394	CcSEcCtD
Dicyclomine—Oedema—Pravastatin—atherosclerosis	0.00273	0.00394	CcSEcCtD
Dicyclomine—Fatigue—Ezetimibe—atherosclerosis	0.00273	0.00394	CcSEcCtD
Dicyclomine—Shock—Niacin—atherosclerosis	0.00273	0.00394	CcSEcCtD
Dicyclomine—Paraesthesia—Simvastatin—atherosclerosis	0.00271	0.00392	CcSEcCtD
Dicyclomine—Constipation—Ezetimibe—atherosclerosis	0.00271	0.00391	CcSEcCtD
Dicyclomine—Pain—Ezetimibe—atherosclerosis	0.00271	0.00391	CcSEcCtD
Dicyclomine—Tachycardia—Niacin—atherosclerosis	0.00271	0.00391	CcSEcCtD
Dicyclomine—Pruritus—Rosuvastatin—atherosclerosis	0.0027	0.00389	CcSEcCtD
Dicyclomine—Dyspnoea—Simvastatin—atherosclerosis	0.00269	0.00389	CcSEcCtD
Dicyclomine—Feeling abnormal—Lovastatin—atherosclerosis	0.00266	0.00384	CcSEcCtD
Dicyclomine—Dyspepsia—Simvastatin—atherosclerosis	0.00266	0.00384	CcSEcCtD
Dicyclomine—Anorexia—Niacin—atherosclerosis	0.00265	0.00382	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00264	0.00381	CcSEcCtD
Dicyclomine—Decreased appetite—Simvastatin—atherosclerosis	0.00263	0.00379	CcSEcCtD
Dicyclomine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00261	0.00377	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00261	0.00376	CcSEcCtD
Dicyclomine—Fatigue—Simvastatin—atherosclerosis	0.00261	0.00376	CcSEcCtD
Dicyclomine—Anorexia—Pravastatin—atherosclerosis	0.0026	0.00376	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00259	0.00374	CcSEcCtD
Dicyclomine—Pain—Simvastatin—atherosclerosis	0.00258	0.00373	CcSEcCtD
Dicyclomine—Constipation—Simvastatin—atherosclerosis	0.00258	0.00373	CcSEcCtD
Dicyclomine—Urticaria—Lovastatin—atherosclerosis	0.00257	0.0037	CcSEcCtD
Dicyclomine—Abdominal pain—Lovastatin—atherosclerosis	0.00255	0.00369	CcSEcCtD
Dicyclomine—Dizziness—Rosuvastatin—atherosclerosis	0.00252	0.00364	CcSEcCtD
Dicyclomine—Urticaria—Ezetimibe—atherosclerosis	0.00252	0.00363	CcSEcCtD
Dicyclomine—Insomnia—Niacin—atherosclerosis	0.00251	0.00362	CcSEcCtD
Dicyclomine—Abdominal pain—Ezetimibe—atherosclerosis	0.00251	0.00361	CcSEcCtD
Dicyclomine—Paraesthesia—Niacin—atherosclerosis	0.00249	0.0036	CcSEcCtD
Dicyclomine—Feeling abnormal—Simvastatin—atherosclerosis	0.00249	0.00359	CcSEcCtD
Dicyclomine—Dyspnoea—Niacin—atherosclerosis	0.00247	0.00357	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00247	0.00357	CcSEcCtD
Dicyclomine—Insomnia—Pravastatin—atherosclerosis	0.00247	0.00357	CcSEcCtD
Dicyclomine—Somnolence—Niacin—atherosclerosis	0.00247	0.00356	CcSEcCtD
Dicyclomine—Paraesthesia—Pravastatin—atherosclerosis	0.00245	0.00354	CcSEcCtD
Dicyclomine—Dyspepsia—Niacin—atherosclerosis	0.00244	0.00352	CcSEcCtD
Dicyclomine—Dyspnoea—Pravastatin—atherosclerosis	0.00244	0.00351	CcSEcCtD
Dicyclomine—Decreased appetite—Niacin—atherosclerosis	0.00241	0.00348	CcSEcCtD
Dicyclomine—Dyspepsia—Pravastatin—atherosclerosis	0.00241	0.00347	CcSEcCtD
Dicyclomine—Rash—Rosuvastatin—atherosclerosis	0.0024	0.00347	CcSEcCtD
Dicyclomine—Dermatitis—Rosuvastatin—atherosclerosis	0.0024	0.00347	CcSEcCtD
Dicyclomine—Urticaria—Simvastatin—atherosclerosis	0.0024	0.00346	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Niacin—atherosclerosis	0.0024	0.00346	CcSEcCtD
Dicyclomine—Abdominal pain—Simvastatin—atherosclerosis	0.00239	0.00345	CcSEcCtD
Dicyclomine—Headache—Rosuvastatin—atherosclerosis	0.00239	0.00345	CcSEcCtD
Dicyclomine—Hypersensitivity—Lovastatin—atherosclerosis	0.00238	0.00343	CcSEcCtD
Dicyclomine—Decreased appetite—Pravastatin—atherosclerosis	0.00238	0.00343	CcSEcCtD
Dicyclomine—Pain—Niacin—atherosclerosis	0.00237	0.00342	CcSEcCtD
Dicyclomine—Fatigue—Pravastatin—atherosclerosis	0.00236	0.0034	CcSEcCtD
Dicyclomine—Constipation—Pravastatin—atherosclerosis	0.00234	0.00337	CcSEcCtD
Dicyclomine—Pain—Pravastatin—atherosclerosis	0.00234	0.00337	CcSEcCtD
Dicyclomine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00233	0.00337	CcSEcCtD
Dicyclomine—Asthenia—Lovastatin—atherosclerosis	0.00232	0.00334	CcSEcCtD
Dicyclomine—Pruritus—Lovastatin—atherosclerosis	0.00229	0.0033	CcSEcCtD
Dicyclomine—Asthenia—Ezetimibe—atherosclerosis	0.00227	0.00328	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Niacin—atherosclerosis	0.00227	0.00327	CcSEcCtD
Dicyclomine—Nausea—Rosuvastatin—atherosclerosis	0.00226	0.00327	CcSEcCtD
Dicyclomine—Feeling abnormal—Pravastatin—atherosclerosis	0.00225	0.00325	CcSEcCtD
Dicyclomine—Pruritus—Ezetimibe—atherosclerosis	0.00224	0.00324	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00223	0.00322	CcSEcCtD
Dicyclomine—Hypersensitivity—Simvastatin—atherosclerosis	0.00223	0.00321	CcSEcCtD
Dicyclomine—Urticaria—Niacin—atherosclerosis	0.0022	0.00318	CcSEcCtD
Dicyclomine—Abdominal pain—Niacin—atherosclerosis	0.00219	0.00317	CcSEcCtD
Dicyclomine—Urticaria—Pravastatin—atherosclerosis	0.00217	0.00313	CcSEcCtD
Dicyclomine—Asthenia—Simvastatin—atherosclerosis	0.00217	0.00313	CcSEcCtD
Dicyclomine—Abdominal pain—Pravastatin—atherosclerosis	0.00216	0.00312	CcSEcCtD
Dicyclomine—Pruritus—Simvastatin—atherosclerosis	0.00214	0.00309	CcSEcCtD
Dicyclomine—Dizziness—Lovastatin—atherosclerosis	0.00214	0.00308	CcSEcCtD
Dicyclomine—Dizziness—Ezetimibe—atherosclerosis	0.0021	0.00302	CcSEcCtD
Dicyclomine—Vomiting—Lovastatin—atherosclerosis	0.00205	0.00296	CcSEcCtD
Dicyclomine—Hypersensitivity—Niacin—atherosclerosis	0.00204	0.00295	CcSEcCtD
Dicyclomine—Rash—Lovastatin—atherosclerosis	0.00204	0.00294	CcSEcCtD
Dicyclomine—Dermatitis—Lovastatin—atherosclerosis	0.00204	0.00294	CcSEcCtD
Dicyclomine—Headache—Lovastatin—atherosclerosis	0.00202	0.00292	CcSEcCtD
Dicyclomine—Vomiting—Ezetimibe—atherosclerosis	0.00201	0.00291	CcSEcCtD
Dicyclomine—Hypersensitivity—Pravastatin—atherosclerosis	0.00201	0.0029	CcSEcCtD
Dicyclomine—Dizziness—Simvastatin—atherosclerosis	0.002	0.00288	CcSEcCtD
Dicyclomine—Rash—Ezetimibe—atherosclerosis	0.002	0.00288	CcSEcCtD
Dicyclomine—Dermatitis—Ezetimibe—atherosclerosis	0.002	0.00288	CcSEcCtD
Dicyclomine—Asthenia—Niacin—atherosclerosis	0.00199	0.00287	CcSEcCtD
Dicyclomine—Headache—Ezetimibe—atherosclerosis	0.00199	0.00286	CcSEcCtD
Dicyclomine—Pruritus—Niacin—atherosclerosis	0.00196	0.00283	CcSEcCtD
Dicyclomine—Asthenia—Pravastatin—atherosclerosis	0.00196	0.00283	CcSEcCtD
Dicyclomine—Pruritus—Pravastatin—atherosclerosis	0.00193	0.00279	CcSEcCtD
Dicyclomine—Vomiting—Simvastatin—atherosclerosis	0.00192	0.00277	CcSEcCtD
Dicyclomine—Nausea—Lovastatin—atherosclerosis	0.00192	0.00277	CcSEcCtD
Dicyclomine—Rash—Simvastatin—atherosclerosis	0.00191	0.00275	CcSEcCtD
Dicyclomine—Dermatitis—Simvastatin—atherosclerosis	0.0019	0.00275	CcSEcCtD
Dicyclomine—Headache—Simvastatin—atherosclerosis	0.00189	0.00273	CcSEcCtD
Dicyclomine—Nausea—Ezetimibe—atherosclerosis	0.00188	0.00272	CcSEcCtD
Dicyclomine—Dizziness—Niacin—atherosclerosis	0.00183	0.00265	CcSEcCtD
Dicyclomine—Dizziness—Pravastatin—atherosclerosis	0.00181	0.00261	CcSEcCtD
Dicyclomine—Nausea—Simvastatin—atherosclerosis	0.0018	0.00259	CcSEcCtD
Dicyclomine—Vomiting—Niacin—atherosclerosis	0.00176	0.00255	CcSEcCtD
Dicyclomine—Rash—Niacin—atherosclerosis	0.00175	0.00252	CcSEcCtD
Dicyclomine—Dermatitis—Niacin—atherosclerosis	0.00175	0.00252	CcSEcCtD
Dicyclomine—Headache—Niacin—atherosclerosis	0.00174	0.00251	CcSEcCtD
Dicyclomine—Vomiting—Pravastatin—atherosclerosis	0.00174	0.00251	CcSEcCtD
Dicyclomine—Rash—Pravastatin—atherosclerosis	0.00172	0.00249	CcSEcCtD
Dicyclomine—Dermatitis—Pravastatin—atherosclerosis	0.00172	0.00248	CcSEcCtD
Dicyclomine—Headache—Pravastatin—atherosclerosis	0.00171	0.00247	CcSEcCtD
Dicyclomine—Nausea—Niacin—atherosclerosis	0.00165	0.00238	CcSEcCtD
Dicyclomine—Nausea—Pravastatin—atherosclerosis	0.00162	0.00234	CcSEcCtD
Dicyclomine—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	0.000134	0.000437	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PRKCG—atherosclerosis	0.000134	0.000436	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—SCARB1—atherosclerosis	0.000134	0.000436	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PLA2G1B—atherosclerosis	0.000134	0.000435	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000133	0.000432	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000132	0.00043	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000131	0.000426	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000131	0.000425	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000129	0.000421	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALOX5—atherosclerosis	0.000129	0.00042	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EDN1—atherosclerosis	0.000129	0.00042	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000128	0.000418	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CCL5—atherosclerosis	0.000128	0.000417	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	0.000128	0.000416	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	0.000127	0.000413	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HMGCR—atherosclerosis	0.000126	0.000412	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000122	0.000397	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	0.000122	0.000396	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VWF—atherosclerosis	0.000121	0.000396	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VWF—atherosclerosis	0.000121	0.000394	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOC3—atherosclerosis	0.000121	0.000393	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	0.00012	0.000392	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOC3—atherosclerosis	0.00012	0.000392	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LDLR—atherosclerosis	0.00012	0.000391	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VWF—atherosclerosis	0.00012	0.000391	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LDLR—atherosclerosis	0.00012	0.00039	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000119	0.000388	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOC3—atherosclerosis	0.000119	0.000388	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LDLR—atherosclerosis	0.000118	0.000386	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000118	0.000385	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	0.000118	0.000384	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL3—atherosclerosis	0.000117	0.000382	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL3—atherosclerosis	0.000117	0.000381	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	0.000117	0.00038	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NAMPT—atherosclerosis	0.000116	0.000377	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL3—atherosclerosis	0.000116	0.000377	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000115	0.000375	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—LIPC—atherosclerosis	0.000115	0.000375	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOC3—atherosclerosis	0.000114	0.000372	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—LDLR—atherosclerosis	0.000114	0.00037	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ABCA1—atherosclerosis	0.000113	0.000367	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NCF1—atherosclerosis	0.000112	0.000366	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NCF1—atherosclerosis	0.000112	0.000364	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CETP—atherosclerosis	0.000111	0.000362	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NCF1—atherosclerosis	0.000111	0.000361	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—F2—atherosclerosis	0.000109	0.000356	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—F2—atherosclerosis	0.000109	0.000355	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—F2—atherosclerosis	0.000108	0.000351	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AGT—atherosclerosis	0.000107	0.00035	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AGT—atherosclerosis	0.000107	0.000349	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SCARB1—atherosclerosis	0.000106	0.000346	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000106	0.000345	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCR2—atherosclerosis	0.000106	0.000345	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AGT—atherosclerosis	0.000106	0.000345	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCR2—atherosclerosis	0.000106	0.000344	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	0.000106	0.000344	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CYBA—atherosclerosis	0.000106	0.000344	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CYBA—atherosclerosis	0.000105	0.000343	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCR2—atherosclerosis	0.000105	0.000341	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	0.000105	0.000341	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000105	0.000341	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000104	0.000339	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CYBA—atherosclerosis	0.000104	0.000339	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000103	0.000337	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PLAT—atherosclerosis	0.000103	0.000336	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PARP1—atherosclerosis	0.000103	0.000336	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GHRL—atherosclerosis	0.000103	0.000336	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000103	0.000336	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PARP1—atherosclerosis	0.000103	0.000335	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PLAT—atherosclerosis	0.000103	0.000335	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GHRL—atherosclerosis	0.000103	0.000335	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GHRL—atherosclerosis	0.000102	0.000332	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PARP1—atherosclerosis	0.000102	0.000332	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PLAT—atherosclerosis	0.000102	0.000332	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMGCR—atherosclerosis	0.0001	0.000327	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—F2—atherosclerosis	9.92e-05	0.000323	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—F2—atherosclerosis	9.89e-05	0.000322	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—F2—atherosclerosis	9.79e-05	0.000319	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—HMOX1—atherosclerosis	9.66e-05	0.000315	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	9.49e-05	0.000309	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	9.46e-05	0.000308	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	9.37e-05	0.000305	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOB—atherosclerosis	9.25e-05	0.000301	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KNG1—atherosclerosis	9.07e-05	0.000295	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.05e-05	0.000295	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KNG1—atherosclerosis	9.04e-05	0.000294	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	9.01e-05	0.000294	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTM1—atherosclerosis	9e-05	0.000293	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	8.98e-05	0.000293	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KNG1—atherosclerosis	8.95e-05	0.000292	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ABCA1—atherosclerosis	8.95e-05	0.000291	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	8.9e-05	0.00029	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	8.84e-05	0.000288	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—LPL—atherosclerosis	8.84e-05	0.000288	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	8.81e-05	0.000287	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PLG—atherosclerosis	8.78e-05	0.000286	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PLG—atherosclerosis	8.75e-05	0.000285	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	8.73e-05	0.000284	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PLG—atherosclerosis	8.67e-05	0.000282	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GPX1—atherosclerosis	8.62e-05	0.000281	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CD36—atherosclerosis	8.4e-05	0.000274	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	8.32e-05	0.000271	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	8.29e-05	0.00027	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	8.21e-05	0.000267	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP3—atherosclerosis	8.03e-05	0.000262	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP3—atherosclerosis	8.01e-05	0.000261	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF2—atherosclerosis	8e-05	0.00026	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF2—atherosclerosis	7.97e-05	0.00026	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—atherosclerosis	7.96e-05	0.000259	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	7.93e-05	0.000258	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	7.89e-05	0.000257	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARA—atherosclerosis	7.81e-05	0.000254	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOB—atherosclerosis	7.76e-05	0.000253	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOB—atherosclerosis	7.74e-05	0.000252	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	7.7e-05	0.000251	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMOX1—atherosclerosis	7.68e-05	0.00025	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	7.67e-05	0.00025	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOB—atherosclerosis	7.66e-05	0.00025	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EDN1—atherosclerosis	7.64e-05	0.000249	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EDN1—atherosclerosis	7.62e-05	0.000248	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	7.6e-05	0.000248	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL5—atherosclerosis	7.58e-05	0.000247	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AGT—atherosclerosis	7.56e-05	0.000246	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL5—atherosclerosis	7.56e-05	0.000246	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	7.54e-05	0.000246	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	7.48e-05	0.000244	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LPL—atherosclerosis	7.41e-05	0.000241	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOE—atherosclerosis	7.41e-05	0.000241	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LPL—atherosclerosis	7.39e-05	0.000241	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOB—atherosclerosis	7.35e-05	0.000239	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CAV1—atherosclerosis	7.34e-05	0.000239	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOA1—atherosclerosis	7.32e-05	0.000239	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LPL—atherosclerosis	7.32e-05	0.000238	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	7.21e-05	0.000235	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	7.18e-05	0.000234	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTM1—atherosclerosis	7.15e-05	0.000233	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	7.11e-05	0.000232	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SPP1—atherosclerosis	7.02e-05	0.000229	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—LPL—atherosclerosis	7.02e-05	0.000229	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SPP1—atherosclerosis	7e-05	0.000228	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	6.99e-05	0.000228	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	6.97e-05	0.000227	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	6.93e-05	0.000226	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	6.9e-05	0.000225	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GPX1—atherosclerosis	6.85e-05	0.000223	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CG—atherosclerosis	6.68e-05	0.000218	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CD36—atherosclerosis	6.67e-05	0.000217	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	6.5e-05	0.000212	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	6.48e-05	0.000211	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARG—atherosclerosis	6.45e-05	0.00021	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	6.41e-05	0.000209	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGT—atherosclerosis	6.34e-05	0.000207	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—INS—atherosclerosis	6.33e-05	0.000206	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGT—atherosclerosis	6.32e-05	0.000206	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—atherosclerosis	6.32e-05	0.000206	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGT—atherosclerosis	6.26e-05	0.000204	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOE—atherosclerosis	6.21e-05	0.000202	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LEP—atherosclerosis	6.21e-05	0.000202	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARA—atherosclerosis	6.2e-05	0.000202	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOE—atherosclerosis	6.19e-05	0.000202	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LEP—atherosclerosis	6.19e-05	0.000202	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CAV1—atherosclerosis	6.16e-05	0.000201	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOA1—atherosclerosis	6.14e-05	0.0002	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CAV1—atherosclerosis	6.14e-05	0.0002	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LEP—atherosclerosis	6.13e-05	0.0002	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOE—atherosclerosis	6.13e-05	0.0002	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOA1—atherosclerosis	6.12e-05	0.000199	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	6.08e-05	0.000198	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	6.06e-05	0.000198	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AGT—atherosclerosis	6.01e-05	0.000196	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ESR1—atherosclerosis	5.93e-05	0.000193	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ESR1—atherosclerosis	5.91e-05	0.000193	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOE—atherosclerosis	5.88e-05	0.000192	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—F2—atherosclerosis	5.86e-05	0.000191	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	5.86e-05	0.000191	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—F2—atherosclerosis	5.84e-05	0.00019	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAV1—atherosclerosis	5.83e-05	0.00019	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOA1—atherosclerosis	5.82e-05	0.000189	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ALB—atherosclerosis	5.8e-05	0.000189	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—F2—atherosclerosis	5.78e-05	0.000188	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	5.61e-05	0.000183	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	5.59e-05	0.000182	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NOS3—atherosclerosis	5.55e-05	0.000181	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	5.54e-05	0.00018	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	5.37e-05	0.000175	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	5.35e-05	0.000174	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CG—atherosclerosis	5.31e-05	0.000173	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—INS—atherosclerosis	5.31e-05	0.000173	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	5.3e-05	0.000173	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—INS—atherosclerosis	5.29e-05	0.000172	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—INS—atherosclerosis	5.24e-05	0.000171	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL2—atherosclerosis	5.22e-05	0.00017	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL2—atherosclerosis	5.21e-05	0.00017	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	5.16e-05	0.000168	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF1—atherosclerosis	5.13e-05	0.000167	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARG—atherosclerosis	5.13e-05	0.000167	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF1—atherosclerosis	5.12e-05	0.000167	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS2—atherosclerosis	5.08e-05	0.000165	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	5.07e-05	0.000165	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—INS—atherosclerosis	5.03e-05	0.000164	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	4.88e-05	0.000159	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	4.86e-05	0.000158	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	4.81e-05	0.000157	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	4.65e-05	0.000152	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOS3—atherosclerosis	4.64e-05	0.000151	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALB—atherosclerosis	4.61e-05	0.00015	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	4.59e-05	0.00015	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NOS3—atherosclerosis	4.41e-05	0.000144	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	4.13e-05	0.000135	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	4.12e-05	0.000134	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	4.08e-05	0.000133	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS2—atherosclerosis	4.03e-05	0.000131	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	3.99e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	3.98e-05	0.00013	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	3.94e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	3.93e-05	0.000128	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	3.91e-05	0.000127	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	3.88e-05	0.000126	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	3.73e-05	0.000122	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	3.72e-05	0.000121	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	3.69e-05	0.00012	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	3.69e-05	0.00012	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	3.68e-05	0.00012	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	3.65e-05	0.000119	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	3.63e-05	0.000118	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	3.62e-05	0.000118	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	3.62e-05	0.000118	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	3.61e-05	0.000118	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	3.59e-05	0.000117	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	3.58e-05	0.000116	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	3.35e-05	0.000109	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	3.34e-05	0.000109	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	3.32e-05	0.000108	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	3.31e-05	0.000108	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	3.31e-05	0.000108	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	3.28e-05	0.000107	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	3.17e-05	0.000103	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	3.16e-05	0.000103	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	3.13e-05	0.000102	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	3.08e-05	0.0001	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	3.07e-05	9.99e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	3.04e-05	9.9e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKT1—atherosclerosis	2.55e-05	8.31e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—atherosclerosis	2.32e-05	7.56e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—atherosclerosis	2.31e-05	7.53e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.29e-05	7.46e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	2.14e-05	6.97e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	2.13e-05	6.95e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	2.11e-05	6.88e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKT1—atherosclerosis	2.03e-05	6.6e-05	CbGpPWpGaD
